| pubmed-article:2641641 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2641641 | lifeskim:mentions | umls-concept:C0024530 | lld:lifeskim |
| pubmed-article:2641641 | lifeskim:mentions | umls-concept:C1280551 | lld:lifeskim |
| pubmed-article:2641641 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:2641641 | lifeskim:mentions | umls-concept:C0025635 | lld:lifeskim |
| pubmed-article:2641641 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:2641641 | lifeskim:mentions | umls-concept:C0205198 | lld:lifeskim |
| pubmed-article:2641641 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:2641641 | pubmed:dateCreated | 1990-10-4 | lld:pubmed |
| pubmed-article:2641641 | pubmed:abstractText | Methemoglobin toxicities of primaquine and compound N1-(3-acetyl-4-5-dihydro-2-furanyl)-N4-(6-methoxy-8-quinolinyl) 1,4-pentanediamine, CDRI Code 80/53, have been compared in beagles. Primaquine administration at 3 mg/kg for 7 days produced significantly high (P less than 0.001) methemoglobinemia and the levels increased 10.55-fold. Compound 80/53 at 3.75 mg/kg x 7 days produced a marginal increase in methemoglobinemia (3.24-fold; P less than 0.02). The methemoglobin formed by primaquine administration was 3.65-fold (P less than 0.001) higher than that formed after administration of compound 80/53. There was no significant change in other hematological parameters and liver function tests. | lld:pubmed |
| pubmed-article:2641641 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2641641 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2641641 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:2641641 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2641641 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2641641 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2641641 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2641641 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2641641 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:2641641 | pubmed:issn | 0002-9637 | lld:pubmed |
| pubmed-article:2641641 | pubmed:author | pubmed-author:DuttaG PGP | lld:pubmed |
| pubmed-article:2641641 | pubmed:author | pubmed-author:SethiNN | lld:pubmed |
| pubmed-article:2641641 | pubmed:author | pubmed-author:RybaDD | lld:pubmed |
| pubmed-article:2641641 | pubmed:author | pubmed-author:PandeyV CVC | lld:pubmed |
| pubmed-article:2641641 | pubmed:author | pubmed-author:SrivastavaRR | lld:pubmed |
| pubmed-article:2641641 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2641641 | pubmed:volume | 41 | lld:pubmed |
| pubmed-article:2641641 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2641641 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2641641 | pubmed:pagination | 638-42 | lld:pubmed |
| pubmed-article:2641641 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:2641641 | pubmed:meshHeading | pubmed-meshheading:2641641-... | lld:pubmed |
| pubmed-article:2641641 | pubmed:meshHeading | pubmed-meshheading:2641641-... | lld:pubmed |
| pubmed-article:2641641 | pubmed:meshHeading | pubmed-meshheading:2641641-... | lld:pubmed |
| pubmed-article:2641641 | pubmed:meshHeading | pubmed-meshheading:2641641-... | lld:pubmed |
| pubmed-article:2641641 | pubmed:meshHeading | pubmed-meshheading:2641641-... | lld:pubmed |
| pubmed-article:2641641 | pubmed:meshHeading | pubmed-meshheading:2641641-... | lld:pubmed |
| pubmed-article:2641641 | pubmed:meshHeading | pubmed-meshheading:2641641-... | lld:pubmed |
| pubmed-article:2641641 | pubmed:meshHeading | pubmed-meshheading:2641641-... | lld:pubmed |
| pubmed-article:2641641 | pubmed:meshHeading | pubmed-meshheading:2641641-... | lld:pubmed |
| pubmed-article:2641641 | pubmed:meshHeading | pubmed-meshheading:2641641-... | lld:pubmed |
| pubmed-article:2641641 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2641641 | pubmed:articleTitle | Methemoglobin toxicity and hematological studies on malaria anti-relapse compound CDRI 80/53 in dogs. | lld:pubmed |
| pubmed-article:2641641 | pubmed:affiliation | Division of Microbiology, Central Drug Research Institute, Lucknow, India. | lld:pubmed |
| pubmed-article:2641641 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2641641 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:2641641 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:2641641 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2641641 | lld:pubmed |
